🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06917352
Active, not recruiting Observational

Clinical Validation of the Norbert Health Device for Pulse Rate Measurement at Vigilant Clinical Testing

NCT06917352 · tracked via the Priya Life Science USA tracker
Sponsor
Norbert Health
Phase
Observational
Started
2025-04-11
Last updated
2025-06-10

Condition(s) studied

Healthy

Investigational drug(s) / intervention(s)

Norbert Device

Norbert Device: The Norbert Device (ND) is a contactless, noninvasive device that provides measurements of pulse rate.

Study summary

The study will evaluate the measuring pulse rate (PR) using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Inclusion Criteria: * Subjects must be 18 years or older * Ability to comprehend written consent and provide informed consent * Ability to commit to and complete study related paperwork and activities (i.e. subject forms, have de-identified pictures taken, comply with periods of no movement, etc.) Exclusion Criteria: * Pregnant women * Diagnosis of essential tremor or any medical condition causing tremors of the head or hands * Facial tattoos, scars, large moles, beards/hair growth, birthmarks, vitiligo, skin conditions, facial discoloration, or heavy makeup within the areas of interest * Inability for subject to avoid extreme movement during measurement reading windows * Inability for subject to raise their hand during measurement reading windows * No heart arrythmias * Discretion of the Principal investigator or clinical study staff

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Vigilant Clinical Testing Irvine California

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06917352 on ClinicalTrials.gov ↗ ← All trials in the USA